← Browse by Condition
Medical Condition
melanoma stage iv
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06771544 Phase 2
Recruiting
Metronomic Cyclophosphamide With Pembrolizumab in Checkpoint Inhibitor Refractory Melanoma
Enrollment
14 pts
Location
United States
Sponsor
University of California, Irvi...
NCT05296564 Phase 1, Phase 2
Recruiting
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Enrollment
3 pts
Location
Israel
Sponsor
Hadassah Medical Organization
NCT05251389 Phase 1, Phase 2
Recruiting
FMT to Convert Response to Immunotherapy
Enrollment
24 pts
Location
Netherlands
Sponsor
The Netherlands Cancer Institu...
NCT06284590 Phase 2
Recruiting
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma Patients
Enrollment
162 pts
Location
United States
Sponsor
Philogen S.p.A.
NCT06295159 Phase 2
Recruiting
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
Enrollment
90 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a...
NCT04045691
Recruiting
Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
Enrollment
750 pts
Location
Austria, Germany, Sw...
Sponsor
Pierre Fabre Pharma GmbH